September Is Prostate Cancer Awareness Month
Knowledge is key
Prostate cancer is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over 75 years old. It is rarely found in men younger than age 40. While one man in seven will get prostate cancer during his lifetime, it is a treatable disease. The Norton Cancer Institute team of specialists can help patients and their families by providing the latest treatment options. Read on to learn about symptoms, risk factors and more.
Signs and symptoms
Common symptoms of prostate cancer include:
- Urinary frequency
- Difficulty with urination
- Pelvic pain
Prevention and early detection
Prostate cancer may be prevented by maintaining a healthy diet. The American Cancer Society recommends a diet low in red meats (especially those high in fat) and high in vegetables, fruits and grains.
Some studies also suggest that taking 50 mg of vitamin E daily can lower the risk of prostate cancer.
If caught early, prostate cancer is very treatable. The American Cancer Society recommends the following:
- Starting at age 50, talk to your doctor about the pros and cons of getting tested.
- Talk to your doctor at age 45, if you are African-American or have a father or brother diagnosed with prostate cancer before age 65.
- This discussion should take place at age 40 for men at even higher risk (those with more than one first-degree relative who had prostate cancer at an early age).
- After this discussion, those men who want to be screened should be tested with the prostate-specific antigen (PSA) blood test. The digital rectal exam (DRE) may also be done as a part of screening.
Some studies also suggest the relationship between a diet high in fat and increased testosterone levels may play a role in the development of prostate cancer, but it is still uncertain what causes the disease. Risk factors include:
- Age – The chance of developing prostate cancer increases with age.
- Race – African-American men are at greater risk than Caucasian men and are twice as likely to die from the disease.
- Nationality – Prostate cancer is most common in North America and northwestern Europe and less common in Asia, Africa, Central America and South America.
- Family history – Prostate cancer seems to run in some families, which suggests that in some cases there may be an inherited or genetic factor.
Norton Cancer Institute is committed to exploring advanced treatment options and counseling for patients with prostate difficulties and cancer. Treatment options are varied and are based on several factors, including the grade/stage of cancer, age and overall health. The most common treatments are:
- External beam radiation therapy
- Surgical removal of the prostate or radical prostatectomy
- Injection therapy
Advanced treatments for prostate cancer available at Norton Cancer Institute
In addition to the latest in radiation therapy technology, Norton Cancer Institute is now offering Xofigo. This newly FDA-approved therapy is now available for the treatment of prostate cancer that is resistant to therapies that lower testosterone and has spread to the bones but not to other parts of the body. Xofigo is an injection administered once a month and has shown to be safe and reduce both broken bones and death in patients with this type of prostate cancer.
Another breakthrough treatment is Calypso, an implantable trackable beacon for prostate cancer irradiation. This allows physicians to reduce the number of treatments from 44 to five in men with early-stage prostate cancer.
As part of our ongoing care, patients and their families have access to numerous resources through our Norton Cancer Institute Resource Centers and our Patient Navigator Program. The resource centers offer educational materials, nutritional counseling, massage therapy and more. Specially trained patient navigator oncology nurses are also available to provide one-on-one educational counseling for patients and family members.
The center also offers the following free services for cancer patients and their families:
- Educational seminars
- Clinical trial searches
- Nutritional counseling
- Emotional/behavioral counseling
- Massage therapy
- Art therapy
- Referrals to community resources
Research and clinical trials
Norton Cancer Institute offers patients the opportunity to participate in innovative National Cancer Institute and industry-sponsored clinical research studies. Find out more about available clinical trials or email us.
We are available to answer any questions you may have about prostate cancer. Email us and you will receive a response within 48 hours (exceptions may include weekends and holidays).
Norton Cancer Institute Resource Center
Medical Towers South, Suite 164
Louisville, KY 40202
(502) 629-5500 | Toll-free: (800) 555-6772